Jiangsu Sihuan Bioengineering Co., Ltd (SHE:000518)
China
· Delayed Price · Currency is CNY 2.890
+0.010 (0.35%)
Apr 30, 2026, 11:54 AM CST
SHE:000518 Revenue
Jiangsu Sihuan Bioengineering had revenue of 81.17M CNY in the quarter ending March 31, 2026, with 85.14% growth. This brings the company's revenue in the last twelve months to 381.71M, up 99.89% year-over-year. In the year 2025, Jiangsu Sihuan Bioengineering had annual revenue of 344.38M with 69.22% growth.
Revenue (ttm)
381.71M
Revenue Growth
+99.89%
P/S Ratio
7.77
Revenue / Employee
1.38M
Employees
277
Market Cap
2.97B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 344.38M | 140.87M | 69.22% |
| Dec 31, 2024 | 203.52M | -31.90M | -13.55% |
| Dec 31, 2023 | 235.42M | -34.73M | -12.86% |
| Jan 1, 2023 | 270.15M | -80.81M | -23.03% |
| Jan 1, 2022 | 350.96M | -154.44M | -30.56% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Guangdong VTR Bio-Tech | 832.26M |
| Shanghai Model Organisms Center | 421.02M |
| Landfar Bio-medicine | 125.47M |
| Yantai Zhenghai Biotechnology | 347.75M |
| Novoprotein Scientific | 151.51M |
| Shenzhen Bioeasy Biotechnology | 263.23M |
| Shanghai Universal Biotech | 1.07B |
| Beijing Kawin Technology Share-Holding | 1.30B |